跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Arglabin
首页
药物
Arglabin
Arglabin
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
METHOD FOR PRODUCTION OF HYDROCHLORIDE 1(10) BETA-EPOXY-13-DIMETHYLAMINO-5,7ALPHA,6,11BETA (H)-GUAIA-3(4)-EN-6,12-OLIDE, THE LYOPHILIZED ANTITUMOR PREPARATION 'ARGLABIN'
US 2009171105 A1
申请人: ADEKENOV SERGAZY MYNZHASAROVICH
优先权: 2006
US
Arglabin的制备方法
CN 103382208 B
申请人: 天津尚德药缘科技有限公司
优先权: 2012
CN
Medicine preparation for treating brain diseases
CN 105381469 A
申请人: UNIV WENZHOU MEDICAL
优先权: 2015
CN
Deuterated arglabin dimethylamine fumarate and preparation method thereof, and application of deuterated dimethylamine fumarate to drug preparation
CN 107840852 A
申请人: ACCENDATECH CO LTD
优先权: 2016
CN
Application of arglabin in preparation of drugs for Stargardt disease
CN 109045022 A
申请人: UNIV XIAMEN
优先权: 2018
CN
愈创木烷倍半萜二聚体的制备方法
CN 113735875 B
申请人: 中国科学院昆明植物研究所
优先权: 2021
CN
Application of arglabin in preparation of medicine for treating or preventing diabetic nephropathy and extraction method of arglabin
CN 115300498 A
申请人: UNIV DALIAN MINZU
优先权: 2022
CN
Application of sesquiterpenoids in whitening
CN 118615181 A
申请人: GUANGZHOU UNIASIA COSMETICS TECH CO LTD
优先权: 2024
CN
Application of arglabin in preventing, relieving or/and treating sepsis cardiomyopathy
CN 119074721 A
申请人: FIRST AFFILIATED HOSPITAL ZHENGZHOU UNIV
优先权: 2024
CN
Application of arglabin in preparation of medicine for treating lipopolysaccharide-induced acute lung injury
CN 119606950 A
申请人: BEIJING CHAO YANG HOSPITAL CAPITAL MEDICAL UNIV
优先权: 2024
CN
药物
反馈